Jazz Pharmaceuticals, Inc. (JAZZ) Net Income by Year
Jazz Pharmaceuticals, Inc. reported a net loss of $356.1M in fiscal year 2025. This represents a decrease of 163.6% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $940.8M in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Jazz Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
JAZZ Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | TTM | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $940.8M | -$356.1M-163.6% | $560.1M+35.0% | $414.8M+285.1% | -$224.1M+32.0% | -$329.7M-238.2% | $238.6M-54.4% | $523.4M+17.1% | $447.1M-8.4% | $487.8M+22.9% | $396.8M+20.4% | $329.5M+464.4% | $58.4M-73.0% | $216.3M-25.0% | $288.6M+130.9% | $125.0M |
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
JAZZ Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Jazz Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Jazz Pharmaceuticals, Inc.'s net income in fiscal year 2025?
Jazz Pharmaceuticals, Inc. reported a net loss of $356.1M in fiscal year 2025.
How fast is Jazz Pharmaceuticals, Inc.'s net income growing?
Jazz Pharmaceuticals, Inc. (JAZZ) net income fell by 163.6% year over year, from $560.1M to -$356.1M in fiscal year 2025.
What is Jazz Pharmaceuticals, Inc.'s net income over the last twelve months?
Jazz Pharmaceuticals, Inc. (JAZZ) reported $940.8M in net income over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Jazz Pharmaceuticals, Inc.'s net income changed over the years?
Across the 15 fiscal years this page covers, Jazz Pharmaceuticals, Inc. (JAZZ) net income went from $125.0M in fiscal year 2011 to -$356.1M in fiscal year 2025.
What was Jazz Pharmaceuticals, Inc.'s net income in the most recent quarter?
Jazz Pharmaceuticals, Inc. (JAZZ) reported $192.8M in net income in Q2 2026. This represents an increase of 126.8% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Jazz Pharmaceuticals, Inc. (JAZZ) reported on that line in every period on record.